Cash flow Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 18/09/2024 BST			Pre-market 12:15:43
6.910 ^USD	+2.22%		7.180	+3.91%

09-03	Jefferies Cuts Price Target on Recursion Pharmaceuticals to $6 From $8, Maintains Hold Rating	MT
09-03	Recursion Pharmaceuticals Says REC-994 Phase 2 Trial Shows Safety and Efficacy Trends	MT

e457170119559d.zbxGmLzdSB_C-CVWFy0T5m74EiNpdD3D0B4boKCX1TE.tfYs682WCUuUrXUmf0p70laQIE0QPFCSmF9_l-6kknn99iSs5OwDebaSfA

Published financial data: RECURSION PHARMACEUTICALS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	2.32M	3.96M	10.18M	39.84M	44.58M
Total Revenues	2.32M	3.96M	10.18M	39.84M	44.58M
Cost of Goods Sold, Total	45.81M	63.32M	135M	204M	284M
Gross Profit	-43.49M	-59.36M	-125M	-164M	-239M
Selling General & Admin Expenses, Total	18.95M	24.62M	57.68M	81.6M	111M
Other Operating Expenses, Total	18.95M	24.62M	57.68M	81.6M	111M
Operating Income	-62.44M	-83.97M	-183M	-246M	-350M
Interest Expense, Total	-635K	-1.36M	-2.95M	-55K	-97K
Interest And Investment Income	1.74M	336K	73K	6.25M	19.12M
Net Interest Expenses	1.11M	-1.02M	-2.88M	6.2M	19.02M
Other Non Operating Income (Expenses)	11K	-484K	2K	52K	-1.09M
EBT, Excl. Unusual Items	-61.32M	-85.48M	-186M	-239M	-332M
Asset Writedown	-	-642K	-	-	-
Other Unusual Items	-555K	-883K	-827K	-	-
EBT, Incl. Unusual Items	-61.88M	-87.01M	-186M	-239M	-332M
Income Tax Expense	-	-	-	-	-4.06M
Earnings From Continuing Operations	-61.88M	-87.01M	-186M	-239M	-328M
Net Income to Company	-61.88M	-87.01M	-186M	-239M	-328M
Net Income - (IS)	-61.88M	-87.01M	-186M	-239M	-328M
Net Income to Common Incl Extra Items	-61.88M	-87.01M	-186M	-239M	-328M
Net Income to Common Excl. Extra Items	-61.88M	-87.01M	-186M	-239M	-328M
Per Share Items
Net EPS - Basic	-2.87	-3.99	-1.49	-1.36	-1.58
Basic EPS - Continuing Operations	-2.87	-3.99	-1.49	-1.36	-1.58
Basic Weighted Average Shares Outstanding	21.57M	21.78M	125M	176M	208M
Net EPS - Diluted	-2.87	-3.99	-1.49	-1.36	-1.58
Diluted EPS - Continuing Operations	-2.87	-3.99	-1.49	-1.36	-1.58
Diluted Weighted Average Shares Outstanding	21.57M	21.78M	125M	176M	208M
Normalized Basic EPS	-1.78	-2.45	-0.93	-0.85	-1
Normalized Diluted EPS	-1.78	-2.45	-0.93	-0.85	-1
Supplemental Items
EBITDA	-58.9M	-80.03M	-174M	-234M	-326M
EBITA	-62.44M	-84.47M	-182M	-245M	-342M
EBIT	-62.44M	-83.97M	-183M	-246M	-350M
EBITDAR	-	-76.32M	-168M	-225M	-315M
Total Revenues (As Reported)	2.32M	3.96M	10.18M	39.84M	44.58M
Effective Tax Rate - (Ratio)	-	-	-	-	1.22
Total Deferred Taxes	-	-	-	-	-4.06M
Normalized Net Income	-38.33M	-53.43M	-116M	-150M	-208M
Interest on Long-Term Debt	1.19M	1.36M	2.95M	55K	97K
Supplemental Operating Expense Items
General and Administrative Expenses	18.95M	20.91M	51.28M	72.74M	100M
Research And Development Expense From Footnotes	45.81M	63.32M	135M	156M	241M
Net Rental Expense, Total	-	3.71M	6.4M	8.86M	10.4M
Imputed Operating Lease Interest Expense	-	3.23M	22.88M	151K	159K
Imputed Operating Lease Depreciation	-	478K	-16.48M	8.71M	10.24M
Stock-Based Comp., COGS (Total)	947K	1.78M	4.98M	13.28M	28.09M
Stock-Based Comp., G&A Exp. (Total)	470K	2.06M	8.99M	14.05M	24.36M
Stock-Based Comp., Other (Total)	-	456K	874K	578K	1.06M
Total Stock-Based Compensation	1.42M	4.29M	14.84M	27.91M	53.5M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	69.88M	262M	285M	550M	392M
Short Term Investments	-	-	231M	-	-
Total Cash And Short Term Investments	69.88M	262M	517M	550M	392M
Accounts Receivable, Total	151K	156K	34K	-	-
Other Receivables	-	-	9.06M	2.75M	3.09M
Total Receivables	151K	156K	9.09M	2.75M	3.09M
Restricted Cash	5.29M	5.04M	1.55M	1.28M	3.23M
Other Current Assets, Total	1.08M	2.16M	7.51M	15.87M	40.25M
Total Current Assets	76.4M	269M	535M	570M	438M
Gross Property Plant And Equipment	30.08M	35.93M	83.46M	152M	165M
Accumulated Depreciation	-5.72M	-9.96M	-18.74M	-30.12M	-44.87M
Net Property Plant And Equipment	24.37M	25.97M	64.72M	121M	120M
Goodwill	-	-	801K	801K	52.06M
Other Intangibles, Total	-	2.49M	1.38M	1.31M	36.44M
Loans Receivable Long-Term	595K	-	-	-	-
Other Long-Term Assets, Total	68K	650K	8.72M	7.92M	6.89M
Total Assets	101M	299M	610M	701M	654M
Liabilities
Accounts Payable, Total	1.26M	1.07M	2.82M	4.59M	3.95M
Accrued Expenses, Total	4.88M	10.48M	27.67M	32.31M	41.76M
Current Portion of Long-Term Debt	77K	1.07M	90K	97K	41K
Current Portion of Leases	-	-	-	5.95M	6.12M
Unearned Revenue Current, Total	-	10M	10M	56.73M	36.43M
Other Current Liabilities	467K	467K	6.08M	591K	4.87M
Total Current Liabilities	6.68M	23.1M	46.66M	100M	93.17M
Long-Term Debt	12.42M	11.41M	633K	536K	1.1M
Long-Term Leases	-	-	-	44.42M	43.41M
Unearned Revenue Non Current	-	16.67M	6.67M	70.26M	51.24M
Deferred Tax Liability Non Current	-	-	-	-	1.34M
Other Non Current Liabilities	5.48M	5.38M	13.45M	-	-
Total Liabilities	24.59M	56.56M	67.41M	215M	190M
Preferred Stock Convertible	201M	448M	-	-	-
Total Preferred Equity	201M	448M	-	-	-
Common Stock, Total	-	-	2K	2K	2K
Additional Paid In Capital	2.33M	7.31M	943M	1.13B	1.43B
Retained Earnings	-127M	-214M	-400M	-640M	-968M
Comprehensive Income and Other	-	-	-126K	-	-
Total Common Equity	-124M	-206M	543M	486M	463M
Total Equity	76.84M	242M	543M	486M	463M
Total Liabilities And Equity	101M	299M	610M	701M	654M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	21.64M	22.31M	171M	191M	235M
ECS Total Common Shares Outstanding	21.64M	22.31M	170M	191M	234M
Book Value / Share	-5.74	-9.24	3.19	2.54	1.98
Tangible Book Value	-124M	-209M	541M	484M	375M
Tangible Book Value Per Share	-5.74	-9.36	3.18	2.53	1.6
Total Debt	12.5M	12.49M	723K	51M	50.67M
Net Debt	-57.39M	-250M	-516M	-499M	-341M
Debt Equivalent Oper. Leases	-	29.65M	51.2M	70.9M	83.19M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	17.19M	20.78M	53.08M	67.69M	82.22M
Full Time Employees	200	331	400	500	500

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-61.88M	-87.01M	-186M	-239M	-328M
Depreciation & Amortization - CF	3.54M	4.44M	8.1M	11.38M	15.9M
Amortization of Goodwill and Intangible Assets - (CF)	-	-499K	304K	379K	8.5M
Depreciation & Amortization, Total	3.54M	3.94M	8.4M	11.76M	24.4M
Asset Writedown & Restructuring Costs	-	874K	-	2.81M	1.19M
Stock-Based Compensation (CF)	1.38M	4.29M	14.84M	27.91M	53.5M
Other Operating Activities, Total	-499K	1.66M	4.92M	8.56M	11.45M
Change In Accounts Receivable	-27K	-5K	114K	-2K	-7.76M
Change In Accounts Payable	-340K	-185K	1.74M	1.77M	-987K
Change in Unearned Revenues	-	26.67M	-10M	110M	-41.08M
Change in Other Net Operating Assets	775K	4.36M	7.84M	-7.16M	-438K
Cash from Operations	-57.04M	-45.4M	-159M	-83.52M	-288M
Capital Expenditure	-3.91M	-5.83M	-39.8M	-37.06M	-11.96M
Cash Acquisitions	-	-2.6M	-	-	1.84M
Sale (Purchase) of Intangible assets	-	-904K	-	-300K	-597K
Investment in Marketable and Equity Securities, Total	-	-	-232M	231M	480K
Other Investing Activities, Total	-	595K	-	-	-
Cash from Investing	-3.91M	-8.74M	-272M	193M	-10.23M
Long-Term Debt Issued, Total	11.89M	6.4M	-	-	-
Total Debt Issued	11.89M	6.4M	-	-	-
Long-Term Debt Repaid, Total	-11.18M	-77K	-12.8M	-90K	-766K
Total Debt Repaid	-11.18M	-77K	-12.8M	-90K	-766K
Issuance of Common Stock	65K	681K	471M	154M	141M
Issuance of Preferred Stock	120M	239M	-	-	-
Other Financing Activities, Total	-275K	-	-	-	-
Cash from Financing	120M	246M	459M	154M	140M
Foreign Exchange Rate Adjustments	-	-	-	-307K	188K
Net Change in Cash	59.46M	192M	28.18M	264M	-158M
Supplemental Items
Cash Interest Paid	485K	989K	680K	55K	96K
Levered Free Cash Flow	-	-37.25M	-122M	-105M	-187M
Unlevered Free Cash Flow	-	-36.4M	-120M	-105M	-187M
Change In Net Working Capital	-	-14.58M	-10.7M	-45.9M	33.87M
Net Debt Issued / Repaid	705K	6.32M	-12.8M	-90K	-766K

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-	-26.24	-25.14	-23.42	-32.29
Return on Total Capital	-	-30.53	-28.62	-28.43	-41.64
Return On Equity %	-	-54.57	-47.51	-46.56	-69.12
Return on Common Equity	-	52.64	-110.79	-46.56	-69.12
Margin Analysis
Gross Profit Margin %	-1.88K	-1.5K	-1.23K	-411.94	-536.71
SG&A Margin	817.21	621.3	566.73	204.8	248.62
EBITDA Margin %	-2.54K	-2.02K	-1.71K	-587.23	-730.58
EBITA Margin %	-2.69K	-2.13K	-1.79K	-615.79	-766.26
EBIT Margin %	-2.69K	-2.12K	-1.8K	-616.74	-785.33
Income From Continuing Operations Margin %	-2.67K	-2.2K	-1.83K	-601.05	-735.99
Net Income Margin %	-2.67K	-2.2K	-1.83K	-601.05	-735.99
Net Avail. For Common Margin %	-2.67K	-2.2K	-1.83K	-601.05	-735.99
Normalized Net Income Margin	-1.65K	-1.35K	-1.14K	-375.66	-465.69
Levered Free Cash Flow Margin	-	-940.21	-1.2K	-264.55	-420.34
Unlevered Free Cash Flow Margin	-	-918.76	-1.18K	-264.47	-420.21
Asset Turnover
Asset Turnover	-	0.02	0.02	0.06	0.07
Fixed Assets Turnover	-	0.16	0.22	0.43	0.37
Receivables Turnover (Average Receivables)	-	25.81	107.14	-	-
Short Term Liquidity
Current Ratio	11.43	11.67	11.46	5.68	4.7
Quick Ratio	10.48	11.35	11.27	5.51	4.24
Operating Cash Flow to Current Liabilities	-8.53	-1.97	-3.4	-0.83	-3.09
Days Sales Outstanding (Average Receivables)	-	14.18	3.41	-	-
Average Days Payable Outstanding	-	6.75	5.25	6.63	5.49
Long Term Solvency
Total Debt/Equity	16.26	5.16	0.13	10.5	10.93
Total Debt / Total Capital	13.99	4.91	0.13	9.5	9.86
LT Debt/Equity	16.16	4.72	0.12	9.25	9.61
Long-Term Debt / Total Capital	13.9	4.48	0.12	8.37	8.66
Total Liabilities / Total Assets	24.24	18.94	11.04	30.73	29.11
EBIT / Interest Expense	-98.33	-61.74	-61.92	-4.47K	-3.61K
EBITDA / Interest Expense	-92.75	-58.85	-59.07	-4.09K	-3.25K
(EBITDA - Capex) / Interest Expense	-98.91	-63.13	-72.55	-4.77K	-3.37K
Total Debt / EBITDA	-0.21	-0.16	-0	-0.23	-0.16
Net Debt / EBITDA	0.97	3.12	2.96	2.22	1.08
Total Debt / (EBITDA - Capex)	-0.2	-0.15	-0	-0.19	-0.15
Net Debt / (EBITDA - Capex)	0.91	2.91	2.41	1.9	1.04
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	70.85	156.89	291.46	11.88
Gross Profit, 1 Yr. Growth %	-	36.48	110.75	31.2	45.76
EBITDA, 1 Yr. Growth %	-	34.74	116.15	34.18	39.19
EBITA, 1 Yr. Growth %	-	34.21	115.97	34.46	39.21
EBIT, 1 Yr. Growth %	-	34.48	116.01	34.44	42.46
Earnings From Cont. Operations, 1 Yr. Growth %	-	40.61	114.33	28.42	36.99
Net Income, 1 Yr. Growth %	-	40.61	114.33	28.42	36.99
Normalized Net Income, 1 Yr. Growth %	-	39.39	115.57	28.99	38.69
Diluted EPS Before Extra, 1 Yr. Growth %	-	39.24	-62.7	-8.3	15.69
Accounts Receivable, 1 Yr. Growth %	-	3.31	-78.21	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-	6.55	149.26	87.64	-1.05
Total Assets, 1 Yr. Growth %	-	194.37	104.41	14.9	-6.79
Tangible Book Value, 1 Yr. Growth %	-	68.01	-359.01	-10.55	-22.49
Common Equity, 1 Yr. Growth %	-	66.01	-363.19	-10.52	-4.6
Cash From Operations, 1 Yr. Growth %	-	-20.41	249.38	-47.34	244.55
Capital Expenditures, 1 Yr. Growth %	-	49.13	582.52	-6.88	-67.74
Levered Free Cash Flow, 1 Yr. Growth %	-	-	252.29	-13.55	77.76
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	255.7	-12.26	77.76
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	109.5	217.12	109.27
Gross Profit, 2 Yr. CAGR %	-	-	69.6	66.29	38.29
EBITDA, 2 Yr. CAGR %	-	-	70.54	70.3	36.66
EBITA, 2 Yr. CAGR %	-	-	70.95	70.41	36.82
EBIT, 2 Yr. CAGR %	-	-	71.09	70.41	38.39
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	73.6	65.9	32.64
Net Income, 2 Yr. CAGR %	-	-	73.6	65.9	32.64
Normalized Net Income, 2 Yr. CAGR %	-	-	73.99	66.75	33.75
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-27.95	-41.56	3
Accounts Receivable, 2 Yr. CAGR %	-	-	-52.55	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	62.97	116.26	36.26
Total Assets, 2 Yr. CAGR %	-	-	145.3	53.25	3.49
Tangible Book Value, 2 Yr. CAGR %	-	-	108.6	52.21	-16.73
Common Equity, 2 Yr. CAGR %	-	-	109.03	53.46	-7.61
Cash From Operations, 2 Yr. CAGR %	-	-	66.75	35.64	34.7
Capital Expenditures, 2 Yr. CAGR %	-	-	219.04	152.1	-45.19
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	74.51	23.96
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	76.67	24.89
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	158.04	124.07
Gross Profit, 3 Yr. CAGR %	-	-	-	55.69	59.14
EBITDA, 3 Yr. CAGR %	-	-	-	57.44	59.23
EBITA, 3 Yr. CAGR %	-	-	-	57.8	59.3
EBIT, 3 Yr. CAGR %	-	-	-	57.88	60.53
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	57	55.65
Net Income, 3 Yr. CAGR %	-	-	-	57	55.65
Normalized Net Income, 3 Yr. CAGR %	-	-	-	57.47	56.82
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-21.96	-26.62
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	70.81	66.65
Total Assets, 3 Yr. CAGR %	-	-	-	90.51	29.85
Tangible Book Value, 3 Yr. CAGR %	-	-	-	57.3	21.55
Common Equity, 3 Yr. CAGR %	-	-	-	57.53	30.97
Cash From Operations, 3 Yr. CAGR %	-	-	-	13.55	85.07
Capital Expenditures, 3 Yr. CAGR %	-	-	-	111.63	27.04
Levered Free Cash Flow, 3 Yr. CAGR %